Molecular mechanisms of epithelial-mesenchymal transition

Nature Reviews Molecular Cell Biology

Volumn 15, Issue 3, 2014, Pages 178-196

  Lamouille, Samy ^a   Xu, Jian ^b   Derynck, Rik ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MOVEMENT; CYTOSKELETON; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MODELS, BIOLOGICAL; RNA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84894593599     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm3758     Document Type: Review

References (275)

1. Hay, E. D. An overview of epithelio-mesenchymal transformation. Acta Anat.154, 8-20 (1995).
2. Thiery, J. P. & Sleeman, J. P. Complex networks orchestrate epithelial-mesenchymal transitions. Nature Rev. Mol. Cell Biol. 7, 131-142 (2006).
3. Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890 (2009).
4. Kalluri, R. & Weinberg, R. A. The basics of epithelialmesenchymal transition. J. Clin. Invest. 119, 1420-1428 (2009).
5. Chapman, H. A. Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu. Rev. Physiol. 73, 413-435 (2011).
6. Huang, R. Y., Guilford, P. & Thiery, J. P. Early events in cell adhesion and polarity during epithelialmesenchymal transition. J. Cell Sci. 125, 4417-4422 (2012).
7. Yilmaz, M. & Christofori, G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 28, 15-33 (2009).
8. Niehrs, C. The complex world of WNT receptor signalling. Nature Rev. Mol. Cell Biol. 13, 767-779 (2012).
9. Kourtidis, A., Ngok, S. P. & Anastasiadis, P. Z. p120 catenin: an essential regulator of cadherin stability, adhesion-induced signaling, and cancer progression. Prog. Mol. Biol. Transl. Sci. 116, 409-432 (2013).
10. Bax, N. A. et al. Epithelial-to-mesenchymal transformation alters electrical conductivity of human epicardial cells. J. Cell. Mol. Med. 15, 2675-2683 (2011).
11. Peinado, H., Olmeda, D. & Cano, A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nature Rev. Cancer 7, 415-428 (2007).
12. De Craene, B. & Berx, G. Regulatory networks defining EMT during cancer initiation and progression. Nature Rev. Cancer 13, 97-110 (2013).
13. St Johnston, D. & Ahringer, J. Cell polarity in eggs and epithelia: parallels and diversity. Cell 141, 757-774 (2010).
14. Navarro, C. et al. Junctional recruitment of mammalian Scribble relies on E-cadherin engagement. Oncogene 24, 4330-4339 (2005).
15. Qin, Y., Capaldo, C., Gumbiner, B. M. & Macara, I. G. The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. J. Cell Biol. 171, 1061-1071 (2005).
16. Moreno-Bueno, G., Portillo, F. & Cano, A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 27, 6958-6969 (2008).
17. Yilmaz, M. & Christofori, G. Mechanisms of motility in metastasizing cells. Mol. Cancer Res. 8, 629-642 (2010).
18. Ridley, A. J. Life at the leading edge. Cell 145, 1012-1022 (2011).
19. McNiven, M. A. Breaking away: matrix remodeling from the leading edge. Trends Cell Biol. 23, 16-21 (2013).
20. Haynes, J. Srivastava, J., Madson, N., Wittmann, T. & Barber, D. L. Dynamic actin remodeling during epithelial-mesenchymal transition depends on increased moesin expression. Mol. Biol. Cell 22, 4750-4764 (2011).
21. Narumiya, S., Tanji, M. & Ishizaki, T. Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev. 28, 65-76 (2009).
22. Whale, A., Hashim, F. N., Fram, S., Jones, G. E. & Wells, C. M. Signalling to cancer cell invasion through PAK family kinases. Front. Biosci. 16, 849-864 (2011).
23. Anastasiadis, P. Z. & Reynolds, A. B. Regulation of Rho GTPases by p120-catenin. Curr. Opin. Cell Biol. 13, 604-610 (2001).
24. Nelson, W. J. Remodeling epithelial cell organization: transitions between front-rear and apical-basal polarity. Cold Spring Harb. Perspect Biol. 1, a000513 (2009).
25. Godde, N. J., Galea, R. C., Elsum, I. A. & Humbert, P. O. Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions. J. Mammary Gland Biol. Neoplasia 15, 149-168 (2010).
26. Wittmann, T., Bokoch, G. M. & Waterman-Storer, C. M. Regulation of leading edge microtubule and actin dynamics downstream of Rac1. J. Cell Biol. 161, 845-851 (2003).
27. Wheelock, M. J., Shintani, Y., Maeda, M., Fukumoto, Y. & Johnson, K. R. Cadherin switching. J. Cell Sci. 121, 727-735 (2008).
28. Theveneau, E. & Mayor, R. Cadherins in collective cell migration of mesenchymal cells. Curr. Opin. Cell Biol. 24, 677-684 (2012).
29. Brieher, W. M. & Yap, A. S. Cadherin junctions and their cytoskeleton(s). Curr. Opin. Cell Biol. 25, 39-46 (2013).
30. Hansen, S. M., Berezin, V. & Bock, E. Signaling mechanisms of neurite outgrowth induced by the cell adhesion molecules NCAM and N-cadherin. Cell. Mol. Life Sci. 65, 3809-3821 (2008).
31. Cavallaro, U. & Christofori, G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nature Rev. Cancer 4, 118-132 (2004).
32. Lehembre, F. et al. NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO J. 27, 2603-2615 (2008).
33. Toivola, D. M., Tao, G. Z., Habtezion, A., Liao, J. & Omary, M. B. Cellular integrity plus: organelle-related and protein-targeting functions of intermediate filaments. Trends Cell Biol. 15, 608-617 (2005).
34. Mendez, M. G., Kojima, S. & Goldman, R. D. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J. 24, 1838-1851 (2010).
35. Yang, X., Pursell, B., Lu, S., Chang, T. K. & Mercurio, A. M. Regulation of ß4-integrin expression by epigenetic modifications in the mammary gland and during the epithelial-to-mesenchymal transition. J. Cell Sci. 122, 2473-2480 (2009).
36. Kim, Y. et al. Integrin a3ß1-dependent ß-catenin phosphorylation links epithelial Smad signaling to cell contacts. J. Cell Biol. 184, 309-322 (2009).
37. Maschler, S. et al. Tumor cell invasiveness correlates with changes in integrin expression and localization. Oncogene 24, 2032-2041 (2005).
38. Mise, N. et al. Zyxin is a transforming growth factor-ß (TGF-ß)/Smad3 target gene that regulates lung cancer cell motility via integrin a5ß1. J. Biol. Chem. 287, 31393-31405 (2012).
39. Koenig, A., Mueller, C., Hasel, C., Adler, G. & Menke, A. Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. Cancer Res. 66, 4662-4671 (2006).
40. Nistico, P., Bissell, M. J. & Radisky, D. C. Epithelialmesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases. Cold Spring Harb Perspect Biol 4, a011908 (2012).
41. Radisky, D. C. et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436, 123-127 (2005).
42. Shah, P. P., Fong, M. Y. & Kakar, S. S. PTTG induces EMT through integrin avß3-focal adhesion kinase signaling in lung cancer cells. Oncogene 31, 3124-3135 (2012).
43. Sheppard, D. Integrin-mediated activation of latent transforming growth factor ß. Cancer Metastasis Rev. 24, 395-402 (2005).
44. Barrallo-Gimeno, A. & Nieto, M. A. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132, 3151-3161 (2005).
45. Xu, J., Lamouille, S. & Derynck, R. TGF-ß-induced epithelial to mesenchymal transition. Cell Res. 19, 156-172 (2009).
46. Batlle, E. et al. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nature Cell Biol. 2, 84-89 (2000).
47. Cano, A. et al. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nature Cell Biol. 2, 76-83 (2000).
48. Lin, T., Ponn, A., Hu, X., Law, B. K. & Lu, J. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene 29, 4896-4904 (2010).
49. Peinado, H., Ballestar, E., Esteller, M. & Cano, A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol. Cell. Biol. 24, 306-319 (2004).
50. Tong, Z. T. et al. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin. Oncogene 31, 583-594 (2012).
51. Herranz, N. et al. Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor. Mol. Cell. Biol. 28, 4772-4781 (2008).
52. Dong, C. et al. Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer. Oncogene 32, 1351-1362 (2013).
53. Dong, C. et al. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J. Clin. Invest. 122, 1469-1486 (2012).
54. Bernstein, B. E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315-326 (2006).
55. Xi, Q. et al. A poised chromatin platform for TGF-ß access to master regulators. Cell 147, 1511-1524 (2011).
56. Jorda, M. et al. Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J. Cell Sci. 118, 3371-3385 (2005).
57. Vincent, T. et al. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-ß mediated epithelial-mesenchymal transition. Nature Cell Biol. 11, 943-950 (2009).
58. Zhou, B. P. et al. Dual regulation of Snail by GSK-3ß-mediated phosphorylation in control of epithelial-mesenchymal transition. Nature Cell Biol. 6, 931-940 (2004).
59. Yook, J. I. et al. A Wnt-Axin2-GSK3ß cascade regulates Snail1 activity in breast cancer cells. Nature Cell Biol. 8, 1398-1406 (2006).
60. Sahlgren, C., Gustafsson, M. V., Jin, S., Poellinger, L. & Lendahl, U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc. Natl Acad. Sci. USA 105, 6392-6397 (2008).
61. Wu, Y. et al. Stabilization of Snail by NF-.B is required for inflammation-induced cell migration and invasion. Cancer Cell 15, 416-428 (2009).
62. Wu, Y., Evers, B. M. & Zhou, B. P. Small C-terminal domain phosphatase enhances snail activity through dephosphorylation. J. Biol. Chem. 284, 640-648 (2009).
63. Du, C., Zhang, C., Hassan, S., Biswas, M. H. & Balaji, K. C. Protein kinase D1 suppresses epithelialto-mesenchymal transition through phosphorylation of snail. Cancer Res. 70, 7810-7819 (2010).
64. Yang, Z. et al. Pak1 phosphorylation of snail, a master regulator of epithelial-to-mesenchyme transition, modulates snail's subcellular localization and functions. Cancer Res. 65, 3179-3184 (2005).
65. Zhang, K. et al. Lats2 kinase potentiates Snail1 activity by promoting nuclear retention upon phosphorylation. EMBO J. 31, 29-43 (2012).
66. Wang, S. P. et al. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nature Cell Biol. 11, 694-704 (2009).
67. Yang, M. H. et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nature Cell Biol. 12, 982-992 (2010).
68. Yang, M. H. et al. Direct regulation of TWIST by HIF-1a promotes metastasis. Nature Cell Biol. 10, 295-305 (2008).
69. Yang, F. et al. SET8 promotes epithelialmesenchymal transition and confers TWIST dual transcriptional activities. EMBO J. 31, 110-123 (2012).
70. Farge, E. Mechanical induction of Twist in the Drosophila foregut/stomodeal primordium. Curr. Biol. 13, 1365-1377 (2003).
71. Kang, Y., Chen, C. R. & Massagué, J. A self-enabling TGFß response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell 11, 915-926 (2003).
72. Hong, J. et al. Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. Cancer Res. 71, 3980-3990 (2011).
73. Sanchez-Tillo, E. et al. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatinremodeling protein BRG1. Oncogene 29, 3490-3500 (2010).
74. Postigo, A. A., Depp, J. L., Taylor, J. J. & Kroll, K. L. Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J. 22, 2453-2462 (2003).
75. Wang, J. et al. Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 446, 882-887 (2007).
76. Dave, N. et al. Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J. Biol. Chem. 286, 12024-12032 (2011).
77. Shirakihara, T., Saitoh, M. & Miyazono, K. Differential regulation of epithelial and mesenchymal markers by dEF1 proteins in epithelial mesenchymal transition induced by TGF-ß. Mol. Biol. Cell 18, 3533-3544 (2007).
78. Long, J., Zuo, D. & Park, M. Pc2-mediated sumoylation of Smad-interacting protein 1 attenuates transcriptional repression of E-cadherin. J. Biol. Chem. 280, 35477-35489 (2005).
79. Eijkelenboom, A. & Burgering, B. M. FOXOs: signalling integrators for homeostasis maintenance. Nature Rev. Mol. Cell Biol. 14, 83-97 (2013).
80. Bresnick, E. H., Lee, H. Y., Fujiwara, T., Johnson, K. D. & Keles, S. GATA switches as developmental drivers. J. Biol. Chem. 285, 31087-31093 (2010).
81. Campbell, K., Whissell, G., Franch-Marro, X., Batlle, E. & Casanova, J. Specific GATA factors act as conserved inducers of an endodermal-EMT. Dev. Cell 21, 1051-1061 (2011).
82. Kondoh, H. & Kamachi, Y. SOX-partner code for cell specification: Regulatory target selection and underlying molecular mechanisms. Int. J. Biochem. Cell Biol. 42, 391-399 (2010).
83. Sakai, D., Suzuki, T., Osumi, N. & Wakamatsu, Y. Cooperative action of Sox9, Snail2 and PKA signaling in early neural crest development. Development 133, 1323-1333 (2006).
84. Guo, W. et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148, 1015-1028 (2012).
85. Brown, R. L. et al. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J. Clin. Invest. 121, 1064-1074 (2011).
86. Shirakihara, T. et al. TGF-ß regulates isoform switching of FGF receptors and epithelial-mesenchymal transition. EMBO J. 30, 783-795 (2011).
87. Warzecha, C. C., Sato, T. K., Nabet, B., Hogenesch, J. B. & Carstens, R. P. ESRP1 and ESRP2 are epithelial celltype-specific regulators of FGFR2 splicing. Mol. Cell 33, 591-601 (2009).
88. Yanagisawa, M. et al. A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic disease. J. Biol. Chem. 283, 18344-18354 (2008).
89. Shapiro, I. M. et al. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet. 7, e1002218 (2011).
90. Warzecha, C. C. et al. An ESRP-regulated splicing programme is abrogated during the epithelialmesenchymal transition. EMBO J. 29, 3286-3300 (2010).
91. Braeutigam, C. et al. The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion. Oncogene http://dx.doi.org/10.1038/onc.2013.50 (2013).
92. Goncalves, V., Matos, P. & Jordan, P. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways. Hum. Mol. Genet. 18, 3696-3707 (2009).
93. Valacca, C. et al. Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene. J. Cell Biol. 191, 87-99 (2010).
94. Lamouille, S., Subramanyam, D., Blelloch, R. & Derynck, R. Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Curr. Opin. Cell Biol. 25, 200-207 (2013).
95. Ru, P. et al. miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling. Mol. Cancer Ther. 11, 1166-1173 (2012).
96. Zhang, J. et al. miR-30 inhibits TGF-ß1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Biochem. Biophys. Res. Commun. 417, 1100-1105 (2012).
97. Liu, Y. N. et al. MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slugindependent mechanisms. Oncogene 32, 296-306 (2012).
98. Siemens, H. et al. miR-34 and SNAIL form a doublenegative feedback loop to regulate epithelialmesenchymal transitions. Cell Cycle 10, 4256-4271 (2011).
99. Moes, M. et al. A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition. PLoS ONE 7, e35440 (2012).
100. Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nature Cell Biol. 10, 593-601 (2008).
101. Bracken, C. P. et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 68, 7846-7854 (2008).
102. Kim, T. et al. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J. Exp. Med. 208, 875-883 (2011).
103. Thuault, S. et al. HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelialto-mesenchymal transition. J. Biol. Chem. 283, 33437-33446 (2008).
104. Watanabe, S. et al. HMGA2 maintains oncogenic RASinduced epithelial-mesenchymal transition in human pancreatic cancer cells. Am. J. Pathol. 174, 854-868 (2009).
105. Qi, J. et al. MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1. Cell Cycle 11, 177-186 (2012).
106. Ma, L. et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nature Cell Biol. 12, 247-256 (2010).
107. Song, Y. et al. Inverse association between miR-194 expression and tumor invasion in gastric cancer. Ann. Surg. Oncol. 19 (Suppl. 3), S509-517 (2012).
108. Meng, Z. et al. miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology 52, 2148-2157 (2010).
109. Zhou, Q. et al. TGF-ß-induced MiR-491-5p expression promotes Par-3 degradation in rat proximal tubular epithelial cells. J. Biol. Chem. 285, 40019-40027 (2010).
110. Vetter, G. et al. miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers. Oncogene 29, 4436-4448 (2010).
111. Kong, W. et al. MicroRNA-155 is regulated by the transforming growth factor ß/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol. 28, 6773-6784 (2008).
112. Papadimitriou, E. et al. Differential regulation of the two RhoA-specific GEF isoforms Net1/Net1A by TGF-ß and miR-24: role in epithelial-to- mesenchymal transition. Oncogene 31, 2862-2875 (2012).
113. Valastyan, S., Chang, A., Benaich, N., Reinhardt, F. & Weinberg, R. A. Concurrent suppression of integrin a5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis. Cancer Res. 70, 5147-5154 (2010).
114. Zheng, F. et al. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 61, 278-289 (2012).
115. Mercado-Pimentel, M. E. & Runyan, R. B. Multiple transforming growth factor-ß isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart. Cells Tissues Organs 185, 146-156 (2007).
116. Nawshad, A., LaGamba, D. & Hay, E. D. Transforming growth factor ß (TGFß) signalling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT). Arch. Oral Biol. 49, 675-689 (2004).
117. Schnaper, H. W., Hayashida, T., Hubchak, S. C. & Poncelet, A. C. TGF-ß signal transduction and mesangial cell fibrogenesis. Am. J. Physiol. Renal Physiol. 284, F243-252 (2003).
118. Gressner, A. M., Weiskirchen, R., Breitkopf, K. & Dooley, S. Roles of TGF-ß in hepatic fibrosis. Front Biosci. 7, d793-807 (2002).
119. Willis, B. C. & Borok, Z. TGF-ß-induced EMT: mechanisms and implications for fibrotic lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L525-534 (2007).
120. Zeisberg, E. M. et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nature Med. 13, 952-961 (2007).
121. Katsuno, Y., Lamouille, S. & Derynck, R. TGF-ß signaling and epithelial-mesenchymal transition in cancer progression. Curr. Opin. Oncol. 25, 76-84 (2013).
122. Portella, G. et al. Transforming growth factor ß is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ. 9, 393-404 (1998).
123. Acloque, H., Adams, M. S., Fishwick, K., Bronner-Fraser, M. & Nieto, M. A. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J. Clin. Invest. 119, 1438-1449 (2009).
124. Sauka-Spengler, T. & Bronner-Fraser, M. A gene regulatory network orchestrates neural crest formation. Nature Rev. Mol. Cell Biol. 9, 557-568 (2008).
125. Kruithof, B. P., Duim, S. N., Moerkamp, A. T. & Goumans, M. J. TGFß and BMP signaling in cardiac cushion formation: lessons from mice and chicken. Differentiation 84, 89-102 (2012).
126. Klattig, J. & Englert, C. The Müllerian duct: recent insights into its development and regression. Sex. Dev. 1, 271-278 (2007).
127. Gordon, K. J., Kirkbride, K. C., How, T. & Blobe, G. C. Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2. Carcinogenesis 30, 238-248 (2009).
128. Zeisberg, M., Shah, A. A. & Kalluri, R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J. Biol. Chem. 280, 8094-8100 (2005).
129. Medici, D. et al. Conversion of vascular endothelial cells into multipotent stem-like cells. Nature Med. 16, 1400-1406 (2010).
130. Feng, X. H. & Derynck, R. Specificity and versatility in TGF-ß signaling through Smads. Annu. Rev. Cell Dev. Biol. 21, 659-693 (2005).
131. Massagué, J. TGFß signalling in context. Nature Rev. Mol. Cell Biol. 13, 616-630 (2012).
132. Miyazono, K., ten Dijke, P. & Heldin, C. H. TGF-ß signaling by Smad proteins. Adv. Immunol. 75, 115-157 (2000).
133. Valcourt, U., Kowanetz, M., Niimi, H., Heldin, C. H. & Moustakas, A. TGF-ß and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol. Biol. Cell 16, 1987-2002 (2005).
134. Lamouille, S. & Derynck, R. Cell size and invasion in TGF-ß-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J. Cell Biol. 178, 437-451 (2007).
135. Piek, E., Moustakas, A., Kurisaki, A., Heldin, C. H. & ten Dijke, P. TGF-ß type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J. Cell Sci. 112, 4557-4568 (1999).
136. Deckers, M. et al. The tumor suppressor Smad4 is required for transforming growth factor ß-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res. 66, 2202-2209 (2006).
137. Zavadil, J. & Böttinger, E. P. TGF-ß and epithelialto-mesenchymal transitions. Oncogene 24, 5764-5774 (2005).
138. Hoot, K. E. et al. Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J. Clin. Invest. 118, 2722-2732 (2008).
139. Ju, W. et al. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol. Cell. Biol. 26, 654-667 (2006).
140. Yang, Y. C. et al. Hierarchical model of gene regulation by transforming growth factor ß. Proc. Natl Acad. Sci. USA 100, 10269-10274 (2003).
141. Morita, T., Mayanagi, T. & Sobue, K. Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling. J. Cell Biol. 179, 1027-1042 (2007).
142. Nishimura, G. et al. dEF1 mediates TGF-ß signaling in vascular smooth muscle cell differentiation. Dev. Cell 11, 93-104 (2006).
143. Postigo, A. A. Opposing functions of ZEB proteins in the regulation of the TGFß/BMP signaling pathway. EMBO J. 22, 2443-2452 (2003).
144. Thuault, S. et al. Transforming growth factor-ß employs HMGA2 to elicit epithelial-mesenchymal transition. J. Cell Biol. 174, 175-183 (2006).
145. Zavadil, J. et al. Genetic programs of epithelial cell plasticity directed by transforming growth factor-ß. Proc. Natl Acad. Sci. USA 98, 6686-6691 (2001).
146. Nawshad, A., Medici, D., Liu, C. C. & Hay, E. D. TGFß3 inhibits E-cadherin gene expression in palate medialedge epithelial cells through a Smad2-Smad4-LEF1 transcription complex. J. Cell Sci. 120, 1646-1653 (2007).
147. Kaimori, A. et al. Transforming growth factor-ß1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J. Biol. Chem. 282, 22089-22101 (2007).
148. Derynck, R. & Zhang, Y. E. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425, 577-584 (2003).
149. Moustakas, A. & Heldin, C. H. Non-Smad TGF-β signals. J. Cell Sci. 118, 3573-3584 (2005).
150. Lamouille, S. & Derynck, R. Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-β-induced epithelial-mesenchymal transition. Cells Tissues Organs 193, 8-22 (2011).
151. Ozdamar, B. et al. Regulation of the polarity protein Par6 by TGFβ receptors controls epithelial cell plasticity. Science 307, 1603-1609 (2005).
152. Bhowmick, N. A. et al. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 12, 27-36 (2001).
153. Shen, X. et al. The activity of guanine exchange factor NET1 is essential for transforming growth factor-β-mediated stress fiber formation. J. Biol. Chem. 276, 15362-15368 (2001).
154. Vardouli, L., Moustakas, A. & Stournaras, C. LIM-kinase 2 and cofilin phosphorylation mediate actin cytoskeleton reorganization induced by transforming growth factor-β. J. Biol. Chem. 280, 11448-11457 (2005).
155. Tavares, A. L., Mercado-Pimentel, M. E., Runyan, R. B. & Kitten, G. T. TGF β-mediated RhoA expression is necessary for epithelial-mesenchymal transition in the embryonic chick heart. Dev. Dyn. 235, 1589-1598 (2006).
156. Tsapara, A. et al. The RhoA activator GEF-H1/Lfc is a transforming growth factor-β target gene and effector that regulates α-smooth muscle actin expression and cell migration. Mol. Biol. Cell 21, 860-870 (2010).
157. Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L. & Arteaga, C. L. Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275, 36803-36810 (2000).
158. Lamouille, S., Connolly, E., Smyth, J. W., Akhurst, R. J. & Derynck, R. TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J. Cell Sci. 125, 1259-1273 (2012).
159. Julien, S. et al. Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26, 7445-7456 (2007).
160. Bachelder, R. E., Yoon, S. O., Franci, C., de Herreros, A. G. & Mercurio, A. M. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J. Cell Biol. 168, 29-33 (2005).
161. Chaudhury, A. et al. TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nature Cell Biol. 12, 286-293 (2010).
162. Kang, J. S., Liu, C. & Derynck, R. New regulatory mechanisms of TGF-β receptor function. Trends Cell Biol. 19, 385-394 (2009).
163. Lee, M. K. et al. TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J. 26, 3957-3967 (2007).
164. Yamashita, M. et al. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β. Mol. Cell 31, 918-924 (2008).
165. Sorrentino, A. et al. The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nature Cell Biol. 10, 1199-1207 (2008).
166. Xie, L. et al. Activation of the Erk pathway is required for TGF-β1-induced EMT in vitro. Neoplasia 6, 603-610 (2004).
167. Yu, L., Hιbert, M. C. & Zhang, Y. E. TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses. EMBO J. 21, 3749-3759 (2002).
168. Grande, M. et al. Transforming growth factor-β and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J. Cell Sci. 115, 4227-4236 (2002).
169. Uttamsingh, S. et al. Synergistic effect between EGF and TGF-β1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene 27, 2626-2634 (2008).
170. Marchetti, A. et al. ERK5/MAPK is activated by TGFβ in hepatocytes and required for the GSK-3β-mediated Snail protein stabilization. Cell Signal 20, 2113-2118 (2008).
171. Sano, Y. et al. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling. J. Biol. Chem. 274, 8949-8957 (1999).
172. Santibanez, J. F. JNK mediates TGF-β1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes. FEBS Lett. 580, 5385-5391 (2006).
173. Stoker, M. & Perryman, M. An epithelial scatter factor released by embryo fibroblasts. J. Cell Sci. 77, 209-223 (1985).
174. Gulhati, P. et al. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res. 71, 3246-3256 (2011).
175. Makrodouli, E. et al. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study. Mol. Cancer 10, 118 (2011).
176. Doehn, U. et al. RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells. Mol. Cell 35, 511-522 (2009).
177. Valles, A. M., Boyer, B., Tarone, G. & Thiery, J. P. α2β1 integrin is required for the collagen and FGF-1 induced cell dispersion in a rat bladder carcinoma cell line. Cell Adhes. Commun. 4, 187-199 (1996).
178. Savagner, P., Yamada, K. M. & Thiery, J. P. The zinc-finger protein Slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J. Cell Biol. 137, 1403-1419 (1997).
179. Billottet, C. et al. Modulation of several waves of gene expression during FGF-1 induced epithelial-mesenchymal transition of carcinoma cells. J. Cell Biochem. 104, 826-839 (2008).
180. Ciruna, B. & Rossant, J. FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev. Cell 1, 37-49 (2001).
181. Sun, X., Meyers, E. N., Lewandoski, M. & Martin, G. R. Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. Genes Dev. 13, 1834-1846 (1999).
182. Grotegut, S., von Schweinitz, D., Christofori, G. & Lehembre, F. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J. 25, 3534-3545 (2006).
183. Hiscox, S. & Jiang, W. G. Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells. Biochem. Biophys. Res. Commun. 261, 406-411 (1999).
184. Romano, L. A. & Runyan, R. B. Slug is an essential target of TGFβ2 signaling in the developing chicken heart. Dev. Biol. 223, 91-102 (2000).
185. Kim, H. J. et al. Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-κB and Snail. Mol. Cell. Biol. 27, 3165-3175 (2007).
186. Graham, T. R. et al. Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res. 68, 2479-2488 (2008).
187. Irie, H. Y. et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J. Cell Biol. 171, 1023-1034 (2005).
188. Canonici, A. et al. Insulin-like growth factor-I receptor, E-cadherin and αv integrin form a dynamic complex under the control of α-catenin. Int. J. Cancer 122, 572-582 (2008).
189. Lu, Z., Ghosh, S., Wang, Z. & Hunter, T. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of β-catenin, and enhanced tumor cell invasion. Cancer Cell 4, 499-515 (2003).
190. Lo, H. W. et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res. 67, 9066-9076 (2007).
191. Ahmed, N. et al. Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am. J.
192. Moody, S. E. et al. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8, 197-209 (2005).
193. Knutson, K. L. et al. Immunoediting of cancers may lead to epithelial to mesenchymal transition. J. Immunol. 177, 1526-1533 (2006).
194. Rangel, M. C. et al. Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer. Am. J. Pathol. 180, 2188-2200 (2012).
195. Strizzi, L. et al. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice. J. Cell. Physiol. 201, 266-276 (2004).
196. Morkel, M. et al. β-catenin regulates Cripto-and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation. Development 130, 6283-6294 (2003).
197. Tao, Q. et al. Maternal Wnt11 activates the canonical wnt signaling pathway required for axis formation in Xenopus embryos. Cell 120, 857-871 (2005).
198. Yang, L., Lin, C. & Liu, Z. R. p68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from beta-catenin. Cell 127, 139-155 (2006).
199. Robbins, J. R., McGuire, P. G., Wehrle-Haller, B. & Rogers, S. L. Diminished matrix metalloproteinase 2 (MMP-2) in ectomesenchyme-derived tissues of the Patch mutant mouse: regulation of MMP-2 by PDGF and effects on mesenchymal cell migration. Dev. Biol. 212, 255-263 (1999).
200. Wanami, L. S., Chen, H. Y., Peiro, S., Garcia de Herreros, A. & Bachelder, R. E. Vascular endothelial growth factor-A stimulates Snail expression in breast tumor cells: implications for tumor progression. Exp. Cell Res. 314, 2448-2453 (2008).
201. Yang, A. D. et al. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res. 66, 46-51 (2006).
202. Peinado, H. et al. Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo. J. Cell Sci. 117, 2827-2839 (2004).
203. Liu, P. et al. Requirement for Wnt3 in vertebrate axis formation. Nature Genet. 22, 361-365 (1999).
204. Popperl, H. et al. Misexpression of Wnt8C in the mouse induces an ectopic embryonic axis and causes a truncation of the anterior neuroectoderm. Development 124, 2997-3005 (1997).
205. Garcia-Castro, M. I., Marcelle, C. & Bronner-Fraser, M. Ectodermal Wnt function as a neural crest inducer. Science 297, 848-851 (2002).
206. Carmona-Fontaine, C. et al. Contact inhibition of locomotion in vivo controls neural crest directional migration. Nature 456, 957-961 (2008).
207. Brabletz, T. et al. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl Acad. Sci. USA 98, 10356-10361 (2001).
208. Briscoe, J. & Therond, P. P. The mechanisms of Hedgehog signalling and its roles in development and disease. Nature Rev. Mol. Cell Biol. 14, 416-429 (2013).
209. Monsoro-Burq, A. H. Sclerotome development and morphogenesis: when experimental embryology meets genetics. Int. J. Dev. Biol. 49, 301-308 (2005).
210. Li, X. et al. Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation. Oncogene 25, 609-621 (2006).
211. Fendrich, V. et al. Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum. Endocr. Relat. Cancer 14, 865-874 (2007).
212. Hori, K., Sen, A. & Artavanis-Tsakonas, S. Notch signaling at a glance. J. Cell Sci. 126, 2135-2140 (2013).
213. Timmerman, L. A. et al. Notch promotes epithelialmesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 18, 99-115 (2004).
214. Niessen, K. et al. Slug is a direct Notch target required for initiation of cardiac cushion cellularization. J. Cell Biol. 182, 315-325 (2008).
215. Xie, M. et al. Activation of Notch-1 enhances epithelialmesenchymal transition in gefitinib-acquired resistant lung cancer cells. J. Cell Biochem. 113, 1501-1513 (2012).
216. Imai, T. et al. Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am. J. Pathol. 163, 1437-1447 (2003).
217. Luo, D., Wang, J., Li, J. & Post, M. Mouse Snail is a target gene for HIF. Mol. Cancer Res. 9, 234-245 (2011).
218. Sullivan, N. J. et al. Interleukin-6 induces an epithelialmesenchymal transition phenotype in human breast cancer cells. Oncogene 28, 2940-2947 (2009).
219. Yadav, A., Kumar, B., Datta, J., Teknos, T. N. & Kumar, P. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol. Cancer Res. 9, 1658-1667 (2011).
220. Fernando R. I., Castillo M. D., Litzinger M., Hamilton D. H., Palena C. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res. 71. 5296-5306 2011
221. Jing, Y., Han, Z., Zhang, S., Liu, Y. & Wei, L. Epithelialmesenchymal transition in tumor microenvironment. Cell Biosci. 1, 29 (2011).
222. Heisenberg, C. P. & Solnica-Krezel, L. Back and forth between cell fate specification and movement during vertebrate gastrulation. Curr. Opin. Genet. Dev. 18, 311-316 (2008).
223. Wendt, M. K., Smith, J. A. & Schiemann, W. P. Transforming growth factor-ß-induced epithelialmesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene 29, 6485-6498 (2010).
224. Yang, J., Dai, C. & Liu, Y. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J. Am. Soc. Nephrol. 16, 68-78 (2005).
225. Aragon, E. et al. A Smad action turnover switch operated by WW domain readers of a phosphoserine code. Genes Dev. 25, 1275-1288 (2011).
226. Fuentealba, L. C. et al. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 131, 980-993 (2007).
227. Grego-Bessa, J., Diez, J., Timmerman, L. & de la Pompa, J. L. Notch and epithelial-mesenchyme transition in development and tumor progression: another turn of the screw. Cell Cycle 3, 718-721 (2004).
228. Zavadil, J., Cermak, L., Soto-Nieves, N. & Bottinger, E. P. Integration of TGF-ß/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 23, 1155-1165 (2004).
229. Eastham, A. M. et al. Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res. 67, 11254-11262 (2007).
230. Ullmann, U. et al. Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions. Mol. Hum. Reprod. 13, 21-32 (2007).
231. Mikkelsen, T. S. et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49-55 (2008).
232. Esteban, M. A. et al. The mesenchymal-to-epithelial transition in somatic cell reprogramming. Curr. Opin. Genet. Dev. 22, 423-428 (2012).
233. Maherali, N. & Hochedlinger, K. TGFß signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr. Biol. 19, 1718-1723 (2009).
234. Samavarchi-Tehrani, P. et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 7, 64-77 (2010).
235. Subramanyam, D. et al. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nature Biotech. 29, 443-448 (2011).
236. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008).
237. Scheel, C. & Weinberg, R. A. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin. Cancer Biol. 22, 396-403 (2012).
238. Brabletz, T., Jung, A., Spaderna, S., Hlubek, F. & Kirchner, T. Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nature Rev. Cancer 5, 744-749 (2005).
239. Shipitsin, M. et al. Molecular definition of breast tumor heterogeneity. Cancer Cell 11, 259-273 (2007).
240. Vermeulen, L. et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nature Cell Biol. 12, 468-476 (2010).
241. Brabletz, T. et al. Nuclear overexpression of the oncoprotein ß-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol. Res. Pract. 194, 701-704 (1998).
242. Espinoza, I., Pochampally, R., Xing, F., Watabe, K. & Miele, L. Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition. Onco Targets Ther. 6, 1249-1259 (2013).
243. Ma, J., Xia, J., Miele, L., Sarkar, F. H. & Wang, Z. Notch signaling pathway in pancreatic cancer progression. Pancreat. Disord. Ther. 3, (2013).
244. Palagani, V. et al. Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by.-secretase inhibitor IX. PLoS ONE 7, e46514 (2012).
245. Smith, A. L. et al. The miR-106b-25 cluster targets Smad7, activates TGF-ß signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 31, 5162-5171 (2012).
246. Li, Z., Yang, C. S., Nakashima, K. & Rana, T. M. Small RNA-mediated regulation of iPS cell generation. EMBO J. 30, 823-834 (2011).
247. Medici, D. & Kalluri, R. Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype. Semin. Cancer Biol. 22, 379-384 (2012).
248. van Meeteren, L. A. & ten Dijke, P. Regulation of endothelial cell plasticity by TGF-ß. Cell Tissue Res. 347, 177-186 (2012).
249. von Gise, A. & Pu, W. T. Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease. Circ. Res. 110, 1628-1645 (2012).
250. Zeisberg, E. M., Potenta, S., Xie, L., Zeisberg, M. & Kalluri, R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 67, 10123-10128 (2007).
251. Medici, D. & Olsen, B. R. The role of endothelialmesenchymal transition in heterotopic ossification. J. Bone Miner. Res. 27, 1619-1622 (2012).
252. Kokudo, T. et al. Snail is required for TGFß-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells. J. Cell Sci. 121, 3317-3324 (2008).
253. Luna-Zurita, L. et al. Integration of a Notch-dependent mesenchymal gene program and BMP2-driven cell invasiveness regulates murine cardiac valve formation. J. Clin. Invest. 120, 3493-3507 (2010).
254. Medici, D., Potenta, S. & Kalluri, R. Transforming growth factor-ß2 promotes Snail-mediated endothelialmesenchymal transition through convergence of Smaddependent and Smad-independent signalling. Biochem. J. 437, 515-520 (2011).
255. Rivera-Feliciano, J. et al. Development of heart valves requires Gata4 expression in endothelial-derived cells. Development 133, 3607-3618 (2006).
256. Quaggin, S. E. & Kapus, A. Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition. Kidney Int. 80, 41-50 (2011).
257. Radisky, D. C., Kenny, P. A. & Bissell, M. J. Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? J. Cell Biochem. 101, 830-839 (2007).
258. Qiu, P. et al. Myocardin enhances Smad3-mediated transforming growth factor-ß1 signaling in a CArG boxindependent manner: Smad-binding element is an important cis element for SM22alpha transcription in vivo. Circ. Res. 97, 983-991 (2005).
259. Mihira, H. et al. TGF-ß-induced mesenchymal transition of MS-1 endothelial cells requires Smad-dependent cooperative activation of Rho signals and MRTF-A. J. Biochem. 151, 145-156 (2012).
260. Masszi, A. et al. Fate-determining mechanisms in epithelial-myofibroblast transition: major inhibitory role for Smad3. J. Cell Biol. 188, 383-399 (2010).
261. Charbonney, E. Speight, P., Masszi, A., Nakano, H. & Kapus, A. ß-catenin and Smad3 regulate the activity and stability of myocardin-related transcription factor during epithelial-myofibroblast transition. Mol. Biol. Cell 22, 4472-4485 (2011).
262. Lim, J. & Thiery, J. P. Epithelial-mesenchymal transitions: insights from development. Development 139, 3471-3486 (2012).
263. Zeisberg, M. & Kalluri, R. Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am. J. Physiol. Cell Physiol. 304, C216-225 (2013).
264. Chaffer, C. L., Thompson, E. W. & Williams, E. D. Mesenchymal to epithelial transition in development and disease. Cells Tissues Organs 185, 7-19 (2007).
265. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
266. Cheung, M. et al. The transcriptional control of trunk neural crest induction, survival, and delamination. Dev. Cell 8, 179-192 (2005).
267. Mani, S. A. et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc. Natl Acad. Sci. USA 104, 10069-10074 (2007).
268. Nilsson, J. et al. Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1. Cancer Res. 70, 2020-2029 (2010).
269. Qiao, Y. et al. FOXQ1 regulates epithelial-mesenchymal transition in human cancers. Cancer Res. 71, 3076-3086 (2011).
270. Belguise, K., Guo, S. & Sonenshein, G. E. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor a expression reversing invasive phenotype of breast cancer cells. Cancer Res. 67, 5763-5770 (2007).
271. Song, Y., Washington, M. K. & Crawford, H. C. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer. Cancer Res. 70, 2115-2125 (2010).
272. McDonald, O. G., Wu, H., Timp, W., Doi, A. & Feinberg, A. P. Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nature Struct. Mol. Biol. 18, 867-874 (2011).
273. Venkov, C. D. et al. A proximal activator of transcription in epithelial-mesenchymal transition. J. Clin. Invest. 117, 482-491 (2007).
274. Slorach, E. M., Chou, J. & Werb, Z. Zeppo1 is a novel metastasis promoter that represses E-cadherin expression and regulates p120-catenin isoform expression and localization. Genes Dev. 25, 471-484 (2011).
275. Ocana, O. H. et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22, 709-724 (2012).